Our in vivo studies suggested that the transient overexpression of miR-323a-5p was enough to halt the proliferation of MYCN-amplified NB cells but not in SK-N-AS xenograft models, probably due to a higher rate of miRNA processing. The gene discussed is MYCN; the disease is neuroblastoma.